Scoop has an Ethical Paywall
A New Drug For Diabetes Complications Trials
A New Drug For Diabetes Complications Trials
PROTEMIX CORPORATION LTD ANNOUNCES THE COMMENCEMENT OF PHASE II TRIALS OF A NEW DRUG FOR DIABETES COMPLICATIONS.
Protemix Corporation Limited today announced it had started a 12 month Phase II clinical trials programme for drug candidate GC811007. The first trial targets the reversal and prevention of cardiomyopathy in patients with Type 2 diabetes. Concurrent Phase II trials of GC811007 will target safety, pharmacology and diabetic nephropathy
Diabetes afflicts around 140 million people worldwide. The disease is associated with long term complications that affect almost every part of the body. More than 50% of patients with Type 2 diabetes die from the effects of cardiovascular disease. Modern drugs and technology have failed to suppress the progression of diabetes and diabetic complications.
Protemix Corporation Ltd is a New Zealand company dedicated to the discovery and development of novel treatments for diabetes.
ENDS
Hugh Grant: Navigating Digital Adoption In New Zealand - Embracing Change For A Bright Future
Dawn Aerospace: Historic Flight - Breaks Sound Barrier And Global Records
SEEK: SEEK NZ Employment Report - October
University of Auckland: Protecting Young Minds With AI
Greenpeace: Greenpeace Calls On Fonterra Investors To Consider Big Picture With Giant Puzzle
Hugh Grant: How New Tech Helps Kids Love Soccer More
